| Date | Time | Source | Headline | Symbol | Company |
| 07/02/2024 | 11:19AM | iHub Newswire | FeaturedBNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth | | |
| 08/13/2007 | 2:39PM | PR Newswire (US) | Forest Laboratories, Inc. Expands Share Repurchase Program | NYSE:FRX | Forest Road Acquisition Corp |
| 07/17/2007 | 9:31AM | PR Newswire (US) | Seven Summits Research Releases Alerts on EBAY, MS, PEP, CFC, and FRX | NYSE:FRX | Forest Road Acquisition Corp |
| 07/17/2007 | 8:07AM | PR Newswire (US) | Forest Laboratories, Inc. Reports Fiscal First Quarter 2008 Earnings Per Share Of $0.83 | NYSE:FRX | Forest Road Acquisition Corp |
| 07/03/2007 | 3:27PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 First Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 05/31/2007 | 5:15PM | PR Newswire (US) | Topline Results of Phase III Study in Acute Ischemic Stroke (Dias-2) Do Not Demonstrate Difference Between Desmoteplase and Plac | NYSE:FRX | Forest Road Acquisition Corp |
| 05/22/2007 | 5:56PM | PR Newswire (US) | Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study for Milnacipran as a Treatme | NYSE:FRX | Forest Road Acquisition Corp |
| 05/21/2007 | 9:00AM | PR Newswire (US) | Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure as Long-Term Monotherapy and in Combination Therapy | NYSE:FRX | Forest Road Acquisition Corp |
| 05/01/2007 | 11:49AM | PR Newswire (US) | Response Submitted to FDA Approvable Letter for Hypertension Compound Nebivolol | NYSE:FRX | |
| 04/24/2007 | 8:58AM | PR Newswire (US) | Forest Laboratories, Inc. Reports Fiscal Year 2007 Fourth Quarter Revenues of $885,000,000, Reported EPS Loss of ($0.75) and Adj | NYSE:FRX | Forest Road Acquisition Corp |
| 04/09/2007 | 4:30PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2007 Fourth Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 02/12/2007 | 4:28PM | PR Newswire (US) | Forest Laboratories Announces Rule 144 Sale by Executive Officer | NYSE:FRX | Forest Road Acquisition Corp |
| 02/06/2007 | 5:30PM | PR Newswire (US) | Forest Laboratories Announces Termination of Agreement for Faropenem | NYSE:FRX | Forest Road Acquisition Corp |
| 01/16/2007 | 9:31AM | PR Newswire (US) | Seven Summits Research releases comments on CSCO, GE, AMD, HOG and FRX | NYSE:FRX | Forest Road Acquisition Corp |
| 01/16/2007 | 8:05AM | PR Newswire (US) | Forest Laboratories, Inc. Reports Q3'07 Diluted Earnings Per Share of $0.78 | NYSE:FRX | Forest Road Acquisition Corp |
| 01/11/2007 | 4:03PM | PR Newswire (US) | Forest Laboratories Announces Completion of Acquisition of Cerexa, Inc. | NYSE:FRX | Forest Road Acquisition Corp |
| 01/05/2007 | 8:55AM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2007 Third Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 12/14/2006 | 9:07AM | PR Newswire (US) | Cerexa to Be Acquired by Forest Laboratories for $480 Million Plus Potential $100 Million Milestone Payment | NYSE:FRX | Forest Road Acquisition Corp |
| 12/14/2006 | 8:29AM | PR Newswire (US) | Forest Laboratories Announces Acquisition of Cerexa, Inc. | NYSE:FRX | Forest Road Acquisition Corp |
| 12/06/2006 | 8:00AM | PR Newswire (US) | Lexapro(R) Demonstrated Significance on Prospectively Defined Efficacy Parameter and Was Better Tolerated Than Cymbalta(R) in Tr | NYSE:FRX | Forest Road Acquisition Corp |
| 12/01/2006 | 11:51AM | PR Newswire (US) | Seven Summits Research Releases Comments on GS, MCD, UAUA, FRX, and GPS | NYSE:FRX | Forest Road Acquisition Corp |
| 10/28/2006 | 12:08AM | PR Newswire (US) | Patient Recruitment to Resume Without Modification of Protocol for Desmoteplase Phase IIB/III Stroke Study DIAS-2 | NYSE:FRX | Forest Road Acquisition Corp |
| 10/28/2006 | 12:08AM | PR Newswire (US) | Patient Recruitment to Resume Without Modification of Protocol for Desmoteplase Phase IIB/III Stroke Study DIAS-2 | NYSE:FRX | Forest Road Acquisition Corp |
| 10/25/2006 | 9:52AM | PR Newswire (US) | Patient Recruitment for Desmoteplase Phase IIB/III Stroke Study DIAS-2 Placed on Hold | NYSE:FRX | Forest Road Acquisition Corp |
| 10/23/2006 | 8:00AM | PR Newswire (US) | U.S. Food and Drug Administration Issues Non-Approvable Letter for Faropenem | NYSE:FRX | Forest Road Acquisition Corp |
| 10/17/2006 | 10:31AM | PR Newswire (US) | Seven Summits Research Releases Alerts on JNJ, EMC, FRX, UTX, and ODP | NYSE:FRX | Forest Road Acquisition Corp |
| 10/17/2006 | 8:57AM | PR Newswire (US) | Forest Laboratories Reports Earnings Per Share of $0.75 for Q2'07 | NYSE:FRX | Forest Road Acquisition Corp |
| 10/05/2006 | 5:51PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2007 Second Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 09/07/2006 | 9:00AM | PR Newswire (US) | Forest Laboratories Inc. Announces Appointment of Dr. Lawrence S. Olanoff as President and Chief Operating Officer | NYSE:FRX | Forest Road Acquisition Corp |
| 07/18/2006 | 10:31AM | PR Newswire (US) | Seven Summits Research Releases Alerts on HPQ, KO, UTX, FRX, and USB | NYSE:FRX | Forest Road Acquisition Corp |